Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
21
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| PORFIDO FRANK L. | Chief Financial Officer | 6 | $9.3K | $0 | 2022-09-16 |
| Baker Christine D. | Director | 6 | $0 | $0 | 2022-09-16 |
| Galaini Barbara | See remarks | 14 | $19.5K | $0 | 2022-09-16 |
| Eckard Jonathan | See Remarks | 13 | $0 | $0 | 2022-09-16 |
| Sokol Gerald H | Director | 14 | $0 | $0 | 2022-09-16 |
| Hoffman Steve | Director, 10% Owner | 110 | $26.5K | $7.19M | 2022-09-16 |
| Biehl James | See Remarks | 25 | $67.8K | $0 | 2022-09-16 |
| Cunningham, Richard Anthony | Chief Executive Officer | 6 | $0 | $0 | 2022-09-16 |
| DeGolyer Donald W | Director | 12 | $0 | $0 | 2022-09-16 |
| Carberry David | Director | 19 | $154.1K | $0 | 2022-09-16 |
| Michels Douglas A | Director | 15 | $113.2K | $0 | 2022-09-16 |
| TYSON TIMOTHY | Director | 16 | $0 | $0 | 2022-09-16 |
| Demurjian Michael | Chief Operating Officer | 174 | $0 | $4.66M | 2022-09-07 |
| Van Tornout Jan M | Acting Chief Medical Officer | 7 | $6.8K | $0 | 2022-04-22 |
| Sturman Paul L | Director | 6 | $0 | $0 | 2021-08-24 |
| Rothman John M. | EVP, Product Development | 1 | $0 | $0 | 2020-08-18 |
| Korfin Michele Ilene | Chief Operating Officer | 3 | $5.2K | $0 | 2020-05-07 |
| Taylor Ben R | President, CFO | 7 | $10.1K | $0 | 2020-05-07 |
| Del Priore Giuseppe | Chief Medical Officer | 3 | $0 | $0 | 2020-05-07 |
| Thompson Tommy G | Director | 3 | $0 | $0 | 2019-08-22 |
| Brown Christopher F | 10% Owner | 4 | $0 | $0 | 2018-02-28 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| DeGolyer Donald W | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 100,000 | — | $0 | 0 | SEC↗ |
| DeGolyer Donald W | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| DeGolyer Donald W | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| DeGolyer Donald W | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| DeGolyer Donald W | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 65,000 | — | $0 | 0 | SEC↗ |
| DeGolyer Donald W | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| Carberry David | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| Carberry David | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 25,000 | — | $0 | 0 | SEC↗ |
| Carberry David | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| Carberry David | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 75,000 | — | $0 | 0 | SEC↗ |
| Carberry David | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| Carberry David | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| Carberry David | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 65,000 | — | $0 | 0 | SEC↗ |
| Baker Christine D. | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 14,666 | — | $0 | 0 | SEC↗ |
| Baker Christine D. | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 36,888 | — | $0 | 0 | SEC↗ |
| Baker Christine D. | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| Biehl James | Chief Legal Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 12,500 | — | $0 | 0 | SEC↗ |
| Biehl James | Chief Legal Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 360,000 | — | $0 | 0 | SEC↗ |
| Biehl James | Chief Legal Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 75,000 | — | $0 | 0 | SEC↗ |
| Biehl James | Chief Legal Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 12,500 | — | $0 | 0 | SEC↗ |
| Biehl James | Chief Legal Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 500,000 | — | $0 | 0 | SEC↗ |
| Biehl James | Chief Legal Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 500,000 | — | $0 | 0 | SEC↗ |
| Biehl James | Chief Legal Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 482,200 | — | $0 | 0 | SEC↗ |
| Biehl James | Chief Legal Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 253,200 | — | $0 | 0 | SEC↗ |
| Cunningham, Richard Anthony | Chief Executive Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 1,326,000 | — | $0 | 0 | SEC↗ |
| Cunningham, Richard Anthony | Chief Executive Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 500,000 | — | $0 | 0 | SEC↗ |
| Cunningham, Richard Anthony | Chief Executive Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 2,000,000 | — | $0 | 0 | SEC↗ |
| Eckard Jonathan | Chief Business Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 500,000 | — | $0 | 0 | SEC↗ |
| Eckard Jonathan | Chief Business Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 150,000 | — | $0 | 0 | SEC↗ |
| Eckard Jonathan | Chief Business Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 150,000 | — | $0 | 0 | SEC↗ |
| Eckard Jonathan | Chief Business Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 370,700 | — | $0 | 0 | SEC↗ |
| Eckard Jonathan | Chief Business Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 300,000 | — | $0 | 0 | SEC↗ |
| Eckard Jonathan | Chief Business Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 431,000 | — | $0 | 0 | SEC↗ |
| Eckard Jonathan | Chief Business Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 482,200 | — | $0 | 0 | SEC↗ |
| Galaini Barbara | See remarks | D To issuer deriv | 2022-09-16 | 2022-09-16 | 258,300 | — | $0 | 0 | SEC↗ |
| Galaini Barbara | See remarks | D To issuer deriv | 2022-09-16 | 2022-09-16 | 280,000 | — | $0 | 0 | SEC↗ |
| Galaini Barbara | See remarks | D To issuer deriv | 2022-09-16 | 2022-09-16 | 225,000 | — | $0 | 0 | SEC↗ |
| Galaini Barbara | See remarks | D To issuer deriv | 2022-09-16 | 2022-09-16 | 179,700 | — | $0 | 0 | SEC↗ |
| Galaini Barbara | See remarks | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| Galaini Barbara | See remarks | D To issuer deriv | 2022-09-16 | 2022-09-16 | 200,000 | — | $0 | 0 | SEC↗ |
| TYSON TIMOTHY | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,058 | — | $0 | 0 | SEC↗ |
| TYSON TIMOTHY | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 25,000 | — | $0 | 0 | SEC↗ |
| TYSON TIMOTHY | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 75,000 | — | $0 | 0 | SEC↗ |
| TYSON TIMOTHY | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| TYSON TIMOTHY | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| TYSON TIMOTHY | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| TYSON TIMOTHY | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| TYSON TIMOTHY | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 65,000 | — | $0 | 0 | SEC↗ |
| Michels Douglas A | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 65,000 | — | $0 | 0 | SEC↗ |
| Michels Douglas A | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| Michels Douglas A | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| Michels Douglas A | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| Michels Douglas A | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 45,833 | — | $0 | 0 | SEC↗ |
| Michels Douglas A | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 100,000 | — | $0 | 0 | SEC↗ |
| PORFIDO FRANK L. | Chief Financial Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 725,000 | — | $0 | 0 | SEC↗ |
| PORFIDO FRANK L. | Chief Financial Officer | D To issuer deriv | 2022-09-16 | 2022-09-16 | 396,800 | — | $0 | 0 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| Sokol Gerald H | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 65,000 | — | $0 | 0 | SEC↗ |
| Sokol Gerald H | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| Sokol Gerald H | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| Sokol Gerald H | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 75,000 | — | $0 | 0 | SEC↗ |
| Sokol Gerald H | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 25,000 | — | $0 | 0 | SEC↗ |
| Sokol Gerald H | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| Sokol Gerald H | Director | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| Carberry David | Director | D To issuer | 2022-09-16 | 2022-09-16 | 100,000 | — | $0 | 0 | SEC↗ |
| Biehl James | Chief Legal Officer | D To issuer | 2022-09-16 | 2022-09-16 | 150 | — | $0 | 0 | SEC↗ |
| Biehl James | Chief Legal Officer | D To issuer | 2022-09-16 | 2022-09-16 | 105,000 | — | $0 | 0 | SEC↗ |
| Galaini Barbara | See remarks | D To issuer | 2022-09-16 | 2022-09-16 | 258,300 | — | $0 | 0 | SEC↗ |
| TYSON TIMOTHY | Director | D To issuer | 2022-09-16 | 2022-09-16 | 5,865 | — | $0 | 0 | SEC↗ |
| Michels Douglas A | Director | D To issuer | 2022-09-16 | 2022-09-16 | 110,000 | — | $0 | 0 | SEC↗ |
| PORFIDO FRANK L. | Chief Financial Officer | D To issuer | 2022-09-16 | 2022-09-16 | 10,000 | — | $0 | 0 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | D To issuer | 2022-09-16 | 2022-09-16 | 20,022,566 | — | $0 | 0 | SEC↗ |
| Sokol Gerald H | Director | D To issuer | 2022-09-16 | 2022-09-16 | 5,865 | — | $0 | 0 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-09-07 | 2022-09-07 | 80,000 | $0.24 | $19.2K | 22,448,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-09-06 | 2022-09-07 | 80,000 | $0.26 | $20.8K | 22,528,846 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | A Award deriv | 2022-08-24 | 2022-08-26 | 88,000 | — | $0 | 88,000 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2022-08-24 | 2022-08-29 | 88,000 | — | $0 | 88,000 | SEC↗ |
| Sokol Gerald H | Director | A Award deriv | 2022-08-24 | 2022-08-29 | 88,000 | — | $0 | 88,000 | SEC↗ |
| Michels Douglas A | Director | A Award deriv | 2022-08-24 | 2022-08-29 | 88,000 | — | $0 | 88,000 | SEC↗ |
| Baker Christine D. | Director | A Award deriv | 2022-08-24 | 2022-08-29 | 88,000 | — | $0 | 88,000 | SEC↗ |
| Carberry David | Director | A Award deriv | 2022-08-24 | 2022-08-29 | 88,000 | — | $0 | 88,000 | SEC↗ |
| DeGolyer Donald W | Director | A Award deriv | 2022-08-24 | 2022-08-29 | 88,000 | — | $0 | 88,000 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-08-23 | 2022-08-23 | 80,000 | $0.29 | $23.2K | 22,608,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-08-22 | 2022-08-23 | 80,000 | $0.29 | $23.2K | 22,688,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-07-26 | 2022-07-26 | 70,000 | $0.29 | $20.3K | 22,768,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-07-25 | 2022-07-26 | 70,000 | $0.29 | $20.3K | 22,838,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-07-12 | 2022-07-12 | 70,000 | $0.29 | $20.3K | 22,908,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-07-11 | 2022-07-12 | 70,000 | $0.29 | $20.3K | 22,978,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-06-28 | 2022-06-28 | 60,000 | $0.27 | $16.2K | 23,048,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-06-27 | 2022-06-27 | 60,000 | $0.26 | $15.6K | 23,108,846 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-06-22 | 2022-06-23 | 78,125 | $0.27 | $21.1K | 20,022,566 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-06-21 | 2022-06-23 | 78,125 | $0.26 | $20.3K | 20,100,691 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-06-15 | 2022-06-15 | 60,000 | $0.26 | $15.6K | 23,168,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-06-14 | 2022-06-15 | 60,000 | $0.25 | $15.0K | 23,228,846 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-06-09 | 2022-06-10 | 78,125 | $0.27 | $21.1K | 20,178,816 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-06-08 | 2022-06-10 | 78,125 | $0.27 | $21.1K | 20,256,941 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-06-01 | 2022-06-02 | 66,903 | $0.25 | $16.7K | 23,288,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-05-31 | 2022-06-02 | 53,097 | $0.25 | $13.3K | 23,355,749 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-05-26 | 2022-05-27 | 78,125 | $0.24 | $18.8K | 20,335,066 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-05-25 | 2022-05-27 | 78,125 | $0.24 | $18.8K | 20,413,191 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-05-17 | 2022-05-17 | 50,000 | $0.25 | $12.5K | 23,408,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-05-16 | 2022-05-17 | 50,000 | $0.25 | $12.5K | 23,458,846 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-05-10 | 2022-05-11 | 78,125 | $0.28 | $21.9K | 20,491,316 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-05-09 | 2022-05-11 | 78,125 | $0.31 | $24.2K | 20,569,441 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-05-03 | 2022-05-03 | 50,000 | $0.32 | $16.0K | 23,508,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-05-02 | 2022-05-03 | 50,000 | $0.31 | $15.5K | 23,558,846 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-04-28 | 2022-04-29 | 78,125 | $0.32 | $25.0K | 20,647,566 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-04-27 | 2022-04-29 | 78,125 | $0.32 | $25.0K | 20,725,691 | SEC↗ |
| Cunningham, Richard Anthony | Chief Executive Officer | A Award deriv | 2022-04-25 | 2022-04-26 | 1,326,000 | — | $0 | 1,326,000 | SEC↗ |
| Eckard Jonathan | Chief Business Officer | A Award deriv | 2022-04-22 | 2022-04-26 | 482,200 | — | $0 | 482,200 | SEC↗ |
| Van Tornout Jan M | Acting Chief Medical Officer | A Award deriv | 2022-04-22 | 2022-04-26 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Biehl James | Chief Legal Officer | A Award deriv | 2022-04-22 | 2022-04-26 | 482,200 | — | $0 | 482,200 | SEC↗ |
| PORFIDO FRANK L. | Chief Financial Officer | A Award deriv | 2022-04-22 | 2022-04-26 | 396,800 | — | $0 | 396,800 | SEC↗ |
| Galaini Barbara | See Remarks | A Award deriv | 2022-04-22 | 2022-04-26 | 258,300 | — | $0 | 258,300 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-04-20 | 2022-04-21 | 40,000 | $0.32 | $12.8K | 23,608,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-04-19 | 2022-04-21 | 40,000 | $0.32 | $12.8K | 23,648,846 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-04-12 | 2022-04-13 | 78,125 | $0.32 | $25.0K | 20,803,816 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-04-12 | 2022-04-13 | 20,000 | $0.34 | $6.8K | 23,688,846 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-04-11 | 2022-04-13 | 78,125 | $0.31 | $24.2K | 20,881,941 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-04-04 | 2022-04-04 | 20,000 | $0.35 | $7.0K | 23,708,846 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-03-29 | 2022-04-01 | 78,125 | $0.36 | $28.1K | 20,960,066 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-03-29 | 2022-03-30 | 78,125 | $0.36 | $28.1K | 20,960,066 | SEC↗ |
| Hoffman Steve | Director, 10% Owner | S Sale | 2022-03-28 | 2022-04-01 | 78,125 | $0.34 | $26.6K | 21,038,191 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-03-28 | 2022-03-29 | 20,000 | $0.35 | $7.0K | 23,728,846 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-03-28 | 2022-03-30 | 78,125 | $0.34 | $26.6K | 21,038,191 | SEC↗ |
| Baker Christine D. | Director | A Award deriv | 2022-03-23 | 2022-03-25 | 176,000 | — | $0 | 176,000 | SEC↗ |
| Baker Christine D. | Director | A Award deriv | 2022-03-23 | 2022-03-25 | 36,888 | — | $0 | 212,888 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-03-21 | 2022-03-21 | 20,000 | $0.33 | $6.6K | 23,748,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-03-14 | 2022-03-14 | 20,000 | $0.30 | $6.0K | 23,768,846 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-03-11 | 2022-03-14 | 78,125 | $0.31 | $24.2K | 21,116,316 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-03-10 | 2022-03-14 | 78,125 | $0.31 | $24.2K | 21,194,441 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-03-07 | 2022-03-08 | 20,000 | $0.29 | $5.8K | 23,788,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-02-28 | 2022-03-01 | 20,000 | $0.31 | $6.2K | 23,808,846 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-02-25 | 2022-02-28 | 78,125 | $0.30 | $23.4K | 21,272,566 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-02-24 | 2022-02-28 | 78,125 | $0.29 | $22.7K | 21,350,691 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-02-22 | 2022-02-23 | 20,000 | $0.32 | $6.4K | 23,828,846 | SEC↗ |
| Van Tornout Jan M | Acting Chief Medical Officer | P Buy | 2022-02-17 | 2022-02-22 | 7,022 | $0.36 | $2.5K | 9,831 | SEC↗ |
| Biehl James | Chief Legal Officer | P Buy | 2022-02-15 | 2022-02-16 | 20,000 | $0.34 | $6.8K | 105,000 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-02-14 | 2022-02-14 | 20,000 | $0.33 | $6.6K | 23,848,846 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-02-08 | 2022-02-09 | 78,125 | $0.36 | $28.1K | 21,428,816 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-02-07 | 2022-02-08 | 20,000 | $0.36 | $7.2K | 23,868,846 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-02-07 | 2022-02-09 | 78,125 | $0.36 | $28.1K | 21,506,941 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-01-31 | 2022-01-31 | 20,000 | $0.34 | $6.8K | 23,888,846 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-01-26 | 2022-01-27 | 78,125 | $0.34 | $26.6K | 21,585,066 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-01-25 | 2022-01-27 | 78,125 | $0.51 | $39.8K | 21,663,191 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-01-24 | 2022-01-25 | 20,000 | $0.52 | $10.4K | 23,908,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-01-20 | 2022-01-21 | 320 | $0.59 | $189 | 23,928,846 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-01-10 | 2022-01-10 | 20,000 | $0.60 | $12.0K | 23,929,166 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-01-06 | 2022-01-07 | 78,125 | $0.62 | $48.4K | 21,741,316 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2022-01-05 | 2022-01-07 | 78,125 | $0.66 | $51.6K | 21,819,441 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2022-01-03 | 2022-01-03 | 20,000 | $0.64 | $12.8K | 23,949,166 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-12-27 | 2021-12-29 | 20,000 | $0.66 | $13.2K | 23,969,166 | SEC↗ |
| Biehl James | Chief Legal Officer | P Buy | 2021-12-23 | 2021-12-27 | 10,000 | $0.65 | $6.5K | 85,000 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-12-21 | 2021-12-21 | 20,000 | $0.70 | $14.0K | 23,989,166 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-12-17 | 2021-12-20 | 78,125 | $0.70 | $54.7K | 21,897,566 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-12-16 | 2021-12-20 | 78,125 | $0.72 | $56.3K | 21,975,691 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-12-13 | 2021-12-14 | 20,000 | $0.75 | $15.0K | 24,009,166 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-12-07 | 2021-12-08 | 20,000 | $0.73 | $14.6K | 24,029,166 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-12-03 | 2021-12-06 | 78,125 | $0.72 | $56.3K | 22,053,816 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-12-02 | 2021-12-06 | 20,000 | $0.75 | $15.0K | 24,049,166 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-12-02 | 2021-12-06 | 78,125 | $0.72 | $56.3K | 22,131,941 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-11-30 | 2021-12-01 | 78,125 | $0.72 | $56.3K | 22,210,066 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-11-29 | 2021-12-01 | 78,125 | $0.74 | $57.8K | 22,288,191 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-11-22 | 2021-11-29 | 9,380 | $0.80 | $7.5K | 24,069,166 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-11-17 | 2021-11-18 | 20,000 | $0.91 | $18.2K | 24,078,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-11-16 | 2021-11-17 | 78,125 | $0.92 | $71.9K | 22,366,316 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-11-15 | 2021-11-17 | 78,125 | $0.92 | $71.9K | 22,444,441 | SEC↗ |
| PORFIDO FRANK L. | Chief Financial Officer | P Buy | 2021-11-12 | 2021-11-15 | 10,000 | $0.93 | $9.3K | 10,000 | SEC↗ |
| Biehl James | Chief Legal Officer | P Buy | 2021-11-12 | 2021-11-15 | 10,000 | $0.95 | $9.5K | 75,000 | SEC↗ |
| Galaini Barbara | See Remarks | P Buy | 2021-11-12 | 2021-11-15 | 10,000 | $0.95 | $9.5K | 20,000 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-11-08 | 2021-11-08 | 20,000 | $1.00 | $20.0K | 24,098,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-11-03 | 2021-11-05 | 20,000 | $1.00 | $20.0K | 24,118,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-10-29 | 2021-10-29 | 20,000 | $0.95 | $19.0K | 24,138,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-10-27 | 2021-10-28 | 78,125 | $0.96 | $75.0K | 22,522,566 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-10-26 | 2021-10-28 | 78,125 | $0.97 | $75.8K | 22,600,691 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-10-20 | 2021-10-22 | 20,000 | $0.97 | $19.4K | 24,158,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-10-13 | 2021-10-14 | 20,000 | $1.00 | $20.0K | 24,178,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-10-05 | 2021-10-06 | 78,125 | $1.00 | $78.1K | 22,678,816 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-10-04 | 2021-10-04 | 20,000 | $1.00 | $20.0K | 24,198,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-10-04 | 2021-10-06 | 78,125 | $1.00 | $78.1K | 22,756,941 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-09-27 | 2021-09-28 | 20,000 | $1.12 | $22.4K | 24,218,546 | SEC↗ |
| Carberry David | Director | P Buy | 2021-09-22 | 2021-09-23 | 50,000 | $1.03 | $51.5K | 100,000 | SEC↗ |
| Carberry David | Director | P Buy | 2021-09-22 | 2021-09-23 | 50,000 | $1.03 | $51.5K | 100,000 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-09-20 | 2021-09-21 | 20,000 | $1.01 | $20.2K | 24,238,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-09-15 | 2021-09-17 | 78,125 | $1.03 | $80.5K | 22,835,066 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-09-15 | 2021-09-17 | 94,725 | $1.03 | $97.6K | 22,913,191 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-09-13 | 2021-09-13 | 20,000 | $1.04 | $20.8K | 24,258,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-09-07 | 2021-09-07 | 20,000 | $1.12 | $22.4K | 24,278,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-09-02 | 2021-09-03 | 170,957 | $1.15 | $196.6K | 23,007,916 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-09-01 | 2021-09-03 | 78,525 | $1.13 | $88.7K | 23,178,873 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-08-30 | 2021-09-01 | 20,000 | $1.10 | $22.0K | 24,298,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-08-26 | 2021-08-27 | 78,125 | $1.08 | $84.4K | 23,257,398 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-08-25 | 2021-08-27 | 78,125 | $1.08 | $84.4K | 23,335,523 | SEC↗ |
| Sturman Paul L | Director | A Award deriv | 2021-08-24 | 2021-08-26 | 88,000 | — | $0 | 88,000 | SEC↗ |
| DeGolyer Donald W | Director | A Award deriv | 2021-08-24 | 2021-08-26 | 88,000 | — | $0 | 88,000 | SEC↗ |
| Carberry David | Director | A Award deriv | 2021-08-24 | 2021-08-26 | 88,000 | — | $0 | 88,000 | SEC↗ |
| Michels Douglas A | Director | A Award deriv | 2021-08-24 | 2021-08-26 | 88,000 | — | $0 | 88,000 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2021-08-24 | 2021-08-26 | 88,000 | — | $0 | 88,000 | SEC↗ |
| Sokol Gerald H | Director | A Award deriv | 2021-08-24 | 2021-08-26 | 88,000 | — | $0 | 88,000 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-08-23 | 2021-08-24 | 20,000 | $1.03 | $20.6K | 24,318,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-08-16 | 2021-08-17 | 20,000 | $1.02 | $20.4K | 24,338,546 | SEC↗ |
| Van Tornout Jan M | Acting Chief Medical Officer | P Buy | 2021-08-12 | 2021-08-16 | 1,000 | $1.05 | $1.1K | 2,809 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-08-09 | 2021-08-10 | 20,000 | $1.15 | $23.0K | 24,358,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-08-04 | 2021-08-05 | 84,225 | $1.07 | $90.1K | 23,413,648 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-08-03 | 2021-08-05 | 94,425 | $1.13 | $106.7K | 23,497,873 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-08-02 | 2021-08-03 | 20,000 | $1.15 | $23.0K | 24,378,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-07-30 | 2021-08-02 | 87,925 | $1.15 | $101.1K | 23,592,298 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-07-29 | 2021-08-02 | 156,275 | $1.20 | $187.5K | 23,680,223 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-07-26 | 2021-07-27 | 20,000 | $1.53 | $30.6K | 24,398,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-07-21 | 2021-07-22 | 78,125 | $1.09 | $85.2K | 23,836,498 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-07-20 | 2021-07-22 | 78,125 | $1.05 | $82.0K | 23,914,623 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-07-19 | 2021-07-19 | 20,000 | $1.02 | $20.4K | 24,418,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-07-12 | 2021-07-12 | 20,000 | $1.16 | $23.2K | 24,438,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-07-06 | 2021-07-06 | 20,000 | $1.18 | $23.6K | 24,458,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-06-28 | 2021-06-29 | 20,000 | $1.32 | $26.4K | 24,478,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-06-21 | 2021-06-22 | 20,000 | $1.26 | $25.2K | 24,498,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-06-18 | 2021-06-21 | 41,250 | $1.29 | $53.2K | 23,992,748 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-06-17 | 2021-06-21 | 41,250 | $1.33 | $54.9K | 24,033,998 | SEC↗ |
| PORFIDO FRANK L. | Chief Financial Officer | A Award deriv | 2021-06-14 | 2021-06-16 | 725,000 | — | $0 | 725,000 | SEC↗ |
| Eckard Jonathan | Chief Business Officer | A Award deriv | 2021-06-14 | 2021-06-16 | 431,000 | — | $0 | 431,000 | SEC↗ |
| Cunningham, Richard Anthony | Chief Executive Officer | A Award deriv | 2021-06-14 | 2021-06-16 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Galaini Barbara | See Remarks | A Award deriv | 2021-06-14 | 2021-06-16 | 280,000 | — | $0 | 280,000 | SEC↗ |
| Biehl James | Chief Legal Officer | A Award deriv | 2021-06-14 | 2021-06-16 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Van Tornout Jan M | Acting Chief Medical Officer | A Award deriv | 2021-06-14 | 2021-06-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-06-14 | 2021-06-14 | 20,000 | $1.43 | $28.6K | 24,518,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-06-09 | 2021-06-10 | 41,250 | $1.58 | $65.2K | 24,075,248 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-06-08 | 2021-06-10 | 41,250 | $1.57 | $64.8K | 24,116,498 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-06-07 | 2021-06-08 | 20,000 | $1.61 | $32.2K | 24,538,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-06-01 | 2021-06-02 | 20,000 | $1.58 | $31.6K | 24,558,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-05-27 | 2021-05-28 | 41,250 | $1.47 | $60.6K | 24,157,748 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-05-26 | 2021-05-28 | 41,250 | $1.38 | $56.9K | 24,198,998 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-05-24 | 2021-05-24 | 20,000 | $1.35 | $27.0K | 24,578,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-05-17 | 2021-05-18 | 20,000 | $1.31 | $26.2K | 24,598,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-05-12 | 2021-05-13 | 41,250 | $1.20 | $49.5K | 24,240,248 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-05-11 | 2021-05-12 | 20,000 | $1.23 | $24.6K | 24,618,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-05-11 | 2021-05-13 | 41,250 | $1.20 | $49.5K | 24,281,498 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-05-03 | 2021-05-04 | 20,000 | $1.50 | $30.0K | 24,638,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-04-28 | 2021-04-29 | 41,750 | $1.57 | $65.5K | 24,322,748 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-04-27 | 2021-04-29 | 41,750 | $1.56 | $65.1K | 24,364,498 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-04-26 | 2021-04-28 | 20,000 | $1.54 | $30.8K | 24,658,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-04-19 | 2021-04-20 | 20,000 | $1.45 | $29.0K | 24,678,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-04-14 | 2021-04-15 | 41,750 | $1.56 | $65.1K | 24,406,248 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-04-13 | 2021-04-15 | 41,750 | $1.51 | $63.0K | 24,447,998 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-04-12 | 2021-04-13 | 20,000 | $1.57 | $31.4K | 24,698,546 | SEC↗ |
| Van Tornout Jan M | Acting Chief Medical Officer | P Buy | 2021-04-07 | 2021-04-14 | 247 | $1.70 | $420 | 1,809 | SEC↗ |
| Van Tornout Jan M | Acting Chief Medical Officer | P Buy | 2021-04-06 | 2021-04-14 | 245 | $1.69 | $414 | 1,562 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-04-05 | 2021-04-07 | 20,000 | $1.78 | $35.6K | 24,718,546 | SEC↗ |
| Van Tornout Jan M | Acting Chief Medical Officer | P Buy | 2021-04-05 | 2021-04-14 | 1,317 | $1.85 | $2.4K | 1,317 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-03-29 | 2021-03-29 | 20,000 | $1.73 | $34.6K | 24,738,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-03-26 | 2021-03-29 | 41,750 | $1.79 | $74.7K | 24,489,748 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-03-25 | 2021-03-29 | 41,750 | $1.79 | $74.7K | 24,531,498 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-03-22 | 2021-03-23 | 20,000 | $2.07 | $41.4K | 24,758,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-03-16 | 2021-03-18 | 20,000 | $2.21 | $44.2K | 24,778,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-03-10 | 2021-03-11 | 41,750 | $1.98 | $82.7K | 24,573,248 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-03-09 | 2021-03-11 | 41,750 | $1.92 | $80.2K | 24,614,998 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-03-08 | 2021-03-08 | 20,000 | $1.85 | $37.0K | 24,798,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-03-01 | 2021-03-01 | 20,000 | $2.10 | $42.0K | 24,818,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-02-25 | 2021-02-26 | 41,750 | $2.13 | $88.9K | 24,656,748 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-02-24 | 2021-02-26 | 41,750 | $2.22 | $92.7K | 24,698,498 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-02-22 | 2021-02-23 | 20,000 | $2.43 | $48.6K | 24,838,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-02-16 | 2021-02-17 | 20,000 | $2.77 | $55.4K | 24,858,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-02-11 | 2021-02-12 | 41,750 | $2.88 | $120.2K | 24,740,248 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-02-10 | 2021-02-12 | 41,750 | $3.01 | $125.7K | 24,781,998 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-02-08 | 2021-02-09 | 20,000 | $2.45 | $49.0K | 24,878,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-02-01 | 2021-02-02 | 20,000 | $1.69 | $33.8K | 24,898,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-01-25 | 2021-01-27 | 20,000 | $2.07 | $41.4K | 24,918,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-01-22 | 2021-01-25 | 45,250 | $1.72 | $77.8K | 25,823,748 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-01-21 | 2021-01-25 | 56,250 | $1.89 | $106.3K | 25,868,998 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-01-19 | 2021-01-21 | 20,000 | $1.95 | $39.0K | 24,938,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-01-11 | 2021-01-12 | 20,000 | $1.62 | $32.4K | 24,958,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-01-06 | 2021-01-07 | 56,250 | $1.41 | $79.3K | 24,925,248 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2021-01-05 | 2021-01-07 | 56,250 | $1.36 | $76.5K | 24,981,498 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2021-01-04 | 2021-01-05 | 20,000 | $1.28 | $25.6K | 24,978,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-12-28 | 2020-12-30 | 20,000 | $1.12 | $22.4K | 24,998,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-12-21 | 2020-12-23 | 20,000 | $1.15 | $23.0K | 25,018,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2020-12-16 | 2020-12-17 | 56,250 | $1.12 | $63.0K | 25,037,748 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2020-12-15 | 2020-12-17 | 56,250 | $1.15 | $64.7K | 25,093,998 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2020-12-14 | 2020-12-15 | 315,367 | $1.20 | $378.4K | 25,150,248 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-12-14 | 2020-12-15 | 20,000 | $1.19 | $23.8K | 25,038,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2020-12-11 | 2020-12-15 | 184,633 | $1.27 | $234.5K | 25,465,615 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-12-07 | 2020-12-08 | 20,000 | $1.07 | $21.4K | 25,058,546 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2020-12-04 | 2020-12-07 | 56,250 | $1.06 | $59.6K | 25,650,248 | SEC↗ |
| Hoffman Steve | Chief Science Officer | S Sale | 2020-12-03 | 2020-12-07 | 68,406 | $1.09 | $74.6K | 25,706,498 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-11-30 | 2020-12-01 | 20,000 | $1.08 | $21.6K | 25,078,546 | SEC↗ |
| Cunningham, Richard Anthony | Chief Executive Officer | A Award deriv | 2020-11-25 | 2020-11-30 | 2,000,000 | — | $0 | 2,000,000 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-11-23 | 2020-11-24 | 20,000 | $0.93 | $18.6K | 25,098,546 | SEC↗ |
| Hoffman Steve | Chief Executive Officer | S Sale | 2020-11-19 | 2020-11-20 | 37,179 | $0.94 | $34.9K | 25,774,904 | SEC↗ |
| Hoffman Steve | Chief Executive Officer | S Sale | 2020-11-18 | 2020-11-20 | 59,442 | $0.94 | $55.9K | 25,812,083 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-11-16 | 2020-11-18 | 20,000 | $0.93 | $18.6K | 25,118,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-11-09 | 2020-11-10 | 20,000 | $0.94 | $18.8K | 25,138,546 | SEC↗ |
| Hoffman Steve | Chief Executive Officer | S Sale | 2020-11-04 | 2020-11-05 | 11,320 | $0.92 | $10.4K | 25,871,525 | SEC↗ |
| Hoffman Steve | Chief Executive Officer | S Sale | 2020-11-03 | 2020-11-05 | 29,561 | $0.89 | $26.3K | 25,882,845 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-11-02 | 2020-11-03 | 20,000 | $0.86 | $17.2K | 25,158,546 | SEC↗ |
| Hoffman Steve | Chief Executive Officer | S Sale | 2020-10-22 | 2020-10-23 | 17,540 | $0.98 | $17.2K | 25,912,406 | SEC↗ |
| Hoffman Steve | Chief Executive Officer | S Sale | 2020-10-21 | 2020-10-23 | 20,302 | $0.98 | $19.9K | 25,929,946 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-10-19 | 2020-10-20 | 20,000 | $1.03 | $20.6K | 25,178,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-10-16 | 2020-10-19 | 20,000 | $1.02 | $20.4K | 25,198,546 | SEC↗ |
| Demurjian Michael | 10% Owner | S Sale | 2020-10-07 | 2020-10-07 | 20,000 | $1.00 | $20.0K | 25,218,546 | SEC↗ |
| Hoffman Steve | Chief Executive Officer | S Sale | 2020-10-07 | 2020-10-08 | 31,250 | $0.99 | $30.9K | 25,950,248 | SEC↗ |
| Hoffman Steve | Chief Executive Officer | S Sale | 2020-10-06 | 2020-10-08 | 31,250 | $0.99 | $30.9K | 25,981,498 | SEC↗ |